BACKGROUND: The aim of this study is to accurately differentiate between benign and malignant small renal masses (SRMs) prior to surgery. METHODS: The study included 144 patients with SRMs <4 cm suspected to be renal cell carcinoma (RCC) based on several imaging examinations, who subsequently underwent partial nephrectomy. Clinicopathological data were analyzed based on the preoperative findings obtained from enhanced computed tomography (CT) as follows: group 1 showing a typical imaging pattern for clear cell RCC (CCRCC), and group 2 showing an imaging pattern atypical of CCRCC. We then evaluated the association between clinicopathological characteristics and pathological diagnosis in order to identify factors which can predict the pathological diagnosis. RESULTS: Based on the criteria, 102 (70.8 %) and 42 (29.2 %) patients were classified into group 1 and group 2, respectively. The only independent factor identified to predict the final pathological diagnosis of the 144 patients was preoperative CT findings. Only 7 (6.9 %) patients were pathologically diagnosed with benign tumors in group 1; however, 13 (31.0 %) of the 42 patients in group 2 appeared to have pathologically confirmed benign tumors. A younger age and lower body mass index (BMI) in group 2 were shown to be independently associated with benign histology on multivariate analysis. CONCLUSIONS: The proportion of patients with benign tumors was comparatively high in those with CT findings atypical for CCRCC; therefore, other clinical parameters, such as age and BMI, should be considered when determining therapeutic strategies for patients with such SRMs.
BACKGROUND: The aim of this study is to accurately differentiate between benign and malignant small renal masses (SRMs) prior to surgery. METHODS: The study included 144 patients with SRMs <4 cm suspected to be renal cell carcinoma (RCC) based on several imaging examinations, who subsequently underwent partial nephrectomy. Clinicopathological data were analyzed based on the preoperative findings obtained from enhanced computed tomography (CT) as follows: group 1 showing a typical imaging pattern for clear cell RCC (CCRCC), and group 2 showing an imaging pattern atypical of CCRCC. We then evaluated the association between clinicopathological characteristics and pathological diagnosis in order to identify factors which can predict the pathological diagnosis. RESULTS: Based on the criteria, 102 (70.8 %) and 42 (29.2 %) patients were classified into group 1 and group 2, respectively. The only independent factor identified to predict the final pathological diagnosis of the 144 patients was preoperative CT findings. Only 7 (6.9 %) patients were pathologically diagnosed with benign tumors in group 1; however, 13 (31.0 %) of the 42 patients in group 2 appeared to have pathologically confirmed benign tumors. A younger age and lower body mass index (BMI) in group 2 were shown to be independently associated with benign histology on multivariate analysis. CONCLUSIONS: The proportion of patients with benign tumors was comparatively high in those with CT findings atypical for CCRCC; therefore, other clinical parameters, such as age and BMI, should be considered when determining therapeutic strategies for patients with such SRMs.
Authors: James McKiernan; Ofer Yossepowitch; Michael W Kattan; Rachel Simmons; Robert J Motzer; Victor E Reuter; Paul Russo Journal: Urology Date: 2002-12 Impact factor: 2.649
Authors: Christopher B Dechet; Horst Zincke; Thomas J Sebo; Bernard F King; Andrew J LeRoy; George M Farrow; Michael L Blute Journal: J Urol Date: 2003-01 Impact factor: 7.450
Authors: John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck Journal: J Natl Cancer Inst Date: 2006-09-20 Impact factor: 13.506
Authors: Alexander Kutikov; Lindsay K Fossett; Parvati Ramchandani; John E Tomaszewski; Evan S Siegelman; Marc P Banner; Keith N Van Arsdalen; Alan J Wein; S Bruce Malkowicz Journal: Urology Date: 2006-10 Impact factor: 2.649
Authors: Phillip M Pierorazio; Elias S Hyams; Salina Tsai; Zhaoyong Feng; Bruce J Trock; Jeffrey K Mullins; Pamela T Johnson; Elliot K Fishman; Mohamad E Allaf Journal: Urology Date: 2013-04-17 Impact factor: 2.649
Authors: Christopher J Kane; Katherine Mallin; Jamie Ritchey; Matthew R Cooperberg; Peter R Carroll Journal: Cancer Date: 2008-07-01 Impact factor: 6.860
Authors: Inderbir S Gill; Surena F Matin; Mihir M Desai; Jihad H Kaouk; Andrew Steinberg; Ed Mascha; Julie Thornton; Mahmoud H Sherief; Brenda Strzempkowski; Andrew C Novick Journal: J Urol Date: 2003-07 Impact factor: 7.450